Biosimilars are subsequent versions of an innovator product and have gained popularity over the last 30 years. This series explores the role of biosimilars, addressing the benefits and challenges of creating them and how they have gained momentum within the pharmaceutical industry, with BioAgilytix’s Global CSO, Dr. Afshin Safavi, and other key figures from pharma, CROs, biotech and academia.
Click for full articleLearn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Platforms
Services
Copyright © 2022 BioAgilytix Labs. All rights reserved.